Rituximab‐combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-200x|57|2|e30-e33

ISSN： 1328-8067

Source： PEDIATRICS INTERNATIONAL, Vol.57, Iss.2, 2015-04, pp. : e30-e33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addition of Rituximab to High-Dose Methotrexate-Based Chemotherapy Improves Survival of Adults with Burkitt Lymphoma/Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 2, 2011-12 ,pp. : 115-117

Karger

Access to resources Recommend Favorite

Prolonged Remission in a Patient with Relapsed Follicular Lymphoma after a Single Course of Rituximab

By  

Oncology Research and Treatment, Vol. 29, Iss. 3, 2006-03 ,pp. : 90-92

Karger

Access to resources Recommend Favorite

Treatment-Related Burkitt’s Lymphoma: Literature Review and Case Report of Successful Treatment with Rituximab Monotherapy

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 211-215

Karger

Access to resources Recommend Favorite

First‐line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate‐to‐severe bullous pemphigoid

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 302-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Breast Lymphoma: Favorable Prognosis after Treatment with Standard Combination Chemotherapy

By  

Oncology Research and Treatment, Vol. 29, Iss. 1-2, 2006-01 ,pp. : 14-18

Karger

Access to resources Recommend Favorite